Benzyl Benzoate

Benzyl Benzoate

DAE Class; Rx

Common Brand Names; ASCABIOL

• Scabicides & pediculocides

Benzyl Benzoate is effective in treatment of scabies and as antipruritic. It has been generally supplanted by lindane.

Benzyl Benzoate is primarily indicated in conditions like Pediculosis pubis and capitis, Scabies.

Benzyl Benzoate is contraindicated in conditions like Broken skin.

The signs and symptoms that are produced after the acute overdosage of Benzyl Benzoate include Convulsions.

The symptomatic adverse reactions produced by Benzyl Benzoate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Skin irritation, Mucous membrane irritation.

Benzyl benzoate should not be used on the face, on broken or inflammed skin and in neonates. In elderly the xerosis of the skin make the skin more susceptible to the drying effects of benzyl benzoate and irritation may be worse in elderly patients. Alternative treatment should be used for the elderly.

Drug should not be given to Geriatrics, and Neonates.

Adults

25 %/As recommended /Topical

Pediatrics

12.5 %/As recommended /Topical

Neonatal

6.5 %/As recommended /Topical

Benzyl Benzoate